Amendment AA2-ASA2-AB68

AB68-ASA2-AA2,47,20 2. The organizations are located in this state or serve residents in this state.

AB68-ASA2-AA2,47,23 3. The organizations restrict eligibility to receive services to individuals who are uninsured, underinsured, or have limited or no access to primary, specialty, or prescription care.

AB68-ASA2-AA2,47,24 4. The organizations provide one or more of the following services:

AB68-ASA2-AA2,48,1 a. Medical care.

AB68-ASA2-AA2,48,2 b. Mental health care.

AB68-ASA2-AA2,48,3 c. Dental care.

AB68-ASA2-AA2,48,4 d. Prescription medications.

AB68-ASA2-AA2,48,7 5. The organizations use volunteer health care professionals, nonclinical volunteers, and partnerships with other health care providers to provide the services under subd. 4.

AB68-ASA2-AA2,48,11 6. The organizations are not federally-qualified health centers as defined in 42 USC 1396d (l) (2) and do not receive reimbursement from the federal centers for medicare and medicaid services under a federally-qualified health center payment methodology.

AB68-ASA2-AA2,365j Section 365j. 250.15 (2) (d) of the statutes is created to read:

AB68-ASA2-AA2,48,13 250.15 (2) (d) To free and charitable clinics, $2,500,000.

AB68-ASA2-AA2,365m Section 365m. 250.20 (7) of the statutes is created to read:

AB68-ASA2-AA2,48,18 250.20 (7) Black women's health grants. From the appropriation under s. 20.435 (1) (cr), the department shall annually award grants in the total amount of $1,750,000 to community-serving organizations that are led by Black women that improve Black women's health in Dane, Milwaukee, Rock, and Kenosha Counties.

AB68-ASA2-AA2,365r Section 365r. 250.20 (8) of the statutes is created to read:

AB68-ASA2-AA2,48,23 250.20 (8) Infant and maternal mortality grants. From the appropriation under s. 20.435 (1) (cr), the department shall annually award grants in the total amount of $1,750,000 to organizations that work to reduce racial disparities related to infant and maternal mortality.”.

AB68-ASA2-AA2,49,2 97. Page 340, line 23: delete the material beginning with that line and ending with page 341, line 2, and substitute:

AB68-ASA2-AA2,49,3 “ Section 366. 254.151 (1m) (g) of the statutes is amended to read:

AB68-ASA2-AA2,49,7 254.151 (1m) (g) In each fiscal year, $125,000 $175,000 to fund lead screening and outreach activities at a community-based human service agency that provides primary health care, health education and social services to low-income individuals in 1st class cities.”.

AB68-ASA2-AA2,49,8 98. Page 341, line 2: after that line insert:

AB68-ASA2-AA2,49,9 “ Section 366g. 255.15 (3) (d) of the statutes is created to read:

AB68-ASA2-AA2,49,13 255.15 (3) (d) From the appropriation under s. 20.435 (1) (fm), the department may develop and implement a public health campaign aimed at the prevention of initiation of tobacco and vapor product use and may award grants for local and regional organizations working on youth vaping and providing cessation services.

AB68-ASA2-AA2,366m Section 366m. 255.15 (4) of the statutes is amended to read:

AB68-ASA2-AA2,49,21 255.15 (4) Reports. Not later than April 15, 2002 2022, and annually thereafter, the department shall submit to the governor and to the chief clerk of each house of the legislature for distribution under s. 13.172 (2) a report that evaluates the success of the grant program programs under sub. (3). The report shall specify the number of grants awarded during the immediately preceding fiscal year and the purpose for which each grant was made. The report shall also specify donations and grants accepted by the department under sub. (5).

AB68-ASA2-AA2,366r Section 366r. 255.45 of the statutes is created to read:

AB68-ASA2-AA2,49,24 255.45 Spinal cord injury research grants and symposia. (1) Definitions. In this section:

AB68-ASA2-AA2,50,1 (a) “Council” means the spinal cord injury council.

AB68-ASA2-AA2,50,2 (b) “Grant program” means the program established under sub. (2).

AB68-ASA2-AA2,50,9 (2) Grant program. The department shall establish a program to award grants to persons in this state for research into spinal cord injuries. The purpose of the grants is to support research into new and innovative treatments and rehabilitative efforts for the functional improvement of people with spinal cord injuries, and research topics may include pharmaceutical, medical device, brain stimulus, and rehabilitative approaches and techniques. Grant recipients shall agree to present their research findings at symposia held by the department under sub. (3).

AB68-ASA2-AA2,50,12 (3) Symposia. The department may hold symposia every 2 years for recipients of grants under the grant program to present findings of research supported by the grants.

AB68-ASA2-AA2,50,16 (4) Grant reports. By January 15 of each year, the department shall submit an annual report to the appropriate standing committees of the legislature under s. 13.172 (3) that identifies the recipients of grants under the grant program and the purposes for which the grants were used.

AB68-ASA2-AA2,50,17 (5) Council. (a) The council shall do all of the following:

AB68-ASA2-AA2,50,19 1. Develop criteria for the department to evaluate and award grants under the grant program.

AB68-ASA2-AA2,50,21 2. Review and make recommendations to the department on applications submitted under the grant program.

AB68-ASA2-AA2,50,22 3. Perform other duties specified by the department.

AB68-ASA2-AA2,51,2 (b) Each member of the council shall disclose in a written statement any financial interest in any organization that the council recommends to receive a grant under the grant program. The council shall include the written statements with its recommendations to the department on grant applications.”.

AB68-ASA2-AA2,51,3 99. Page 354, line 23: after that line insert:

AB68-ASA2-AA2,51,4 “ Section 411d. 601.41 (13) of the statutes is created to read:

AB68-ASA2-AA2,51,10 601.41 (13) Value-based diabetes medication pilot project. The commissioner shall develop a pilot project to direct a pharmacy benefit manager, as defined in s. 632.865 (1) (c), and a pharmaceutical manufacturer to create a value-based, sole-source arrangement to reduce the costs of prescription medication used to treat diabetes. The commissioner may promulgate rules to implement this subsection.

AB68-ASA2-AA2,411f Section 411f. 601.415 (14) of the statutes is created to read:

AB68-ASA2-AA2,51,17 601.415 (14) Patient pharmacy benefits tool. (a) From the appropriation under s. 20.145 (1) (a), beginning in the 2022-23 fiscal year, the office shall award grants in a total amount of up to $500,000 each fiscal year to health care providers to develop and implement a tool for prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients.

AB68-ASA2-AA2,51,19 (b) Any health care provider that receives a grant under par. (a) shall contribute matching funds equal to at least 50 percent of the grant amount awarded.

AB68-ASA2-AA2,411h Section 411h. 601.575 of the statutes is created to read:

AB68-ASA2-AA2,52,2 601.575 Prescription drug importation program. (1) Importation program requirements. The commissioner, in consultation with persons interested in the sale and pricing of prescription drugs and appropriate officials and agencies of the federal government, shall design and implement a prescription drug importation program for the benefit of residents of this state, that generates savings for residents, and that satisfies all of the following:

AB68-ASA2-AA2,52,5 (a) The commissioner shall designate a state agency to become a licensed wholesale distributor or to contract with a licensed wholesale distributor and shall seek federal certification and approval to import prescription drugs.

AB68-ASA2-AA2,52,8 (b) The prescription drug importation program under this section shall comply with relevant requirements of 21 USC 384, including safety and cost savings requirements.

AB68-ASA2-AA2,52,11 (c) The prescription drug importation program under this section shall import prescription drugs from Canadian suppliers regulated under any appropriate Canadian or provincial laws.

AB68-ASA2-AA2,52,14 (d) The prescription drug importation program under this section shall have a process to sample the purity, chemical composition, and potency of imported prescription drugs.

AB68-ASA2-AA2,52,18 (e) The prescription drug importation program under this section shall import only those prescription drugs for which importation creates substantial savings for residents of the state and only those prescription drugs that are not brand-name drugs and that have fewer than 4 competitor prescription drugs in the United States.

AB68-ASA2-AA2,52,21 (f) The commissioner shall ensure that prescription drugs imported under the program under this section are not distributed, dispensed, or sold outside of the state.

AB68-ASA2-AA2,52,23 (g) The prescription drug importation program under this section shall ensure all of the following:

AB68-ASA2-AA2,52,25 1. Participation by any pharmacy or health care provider in the program is voluntary.

AB68-ASA2-AA2,53,2 2. Any pharmacy or health care provider participating in the program has the appropriate license or other credential in this state.

AB68-ASA2-AA2,53,5 3. Any pharmacy or health care provider participating in the program charges a consumer or health plan the actual acquisition cost of the imported prescription drug that is dispensed.

AB68-ASA2-AA2,53,9 (h) The prescription drug importation program under this section shall ensure that a payment by a health plan or health insurance policy for a prescription drug imported under the program reimburses no more than the actual acquisition cost of the imported prescription drug that is dispensed.

AB68-ASA2-AA2,53,12 (i) The prescription drug importation program under this section shall ensure that any health plan or health insurance policy participating in the program does all of the following:

AB68-ASA2-AA2,53,14 1. Maintains a formulary and claims payment system with current information on prescription drugs imported under the program.

AB68-ASA2-AA2,53,17 2. Bases cost-sharing amounts for participants or insureds under the plan or policy on no more than the actual acquisition cost of the prescription drug imported under the program that is dispensed to the participant or insured.

AB68-ASA2-AA2,53,20 3. Demonstrates to the commissioner or a state agency designated by the commissioner how premiums under the policy or plan are affected by savings on prescription drugs imported under the program.

AB68-ASA2-AA2,53,23 (j) Any wholesale distributor importing prescription drugs under the program under this section shall limit its profit margin to the amount established by the commissioner or a state agency designated by the commissioner.

AB68-ASA2-AA2,54,3 (k) The prescription drug importation program under this section may not import any generic prescription drug that would violate federal patent laws on branded products in this country.

AB68-ASA2-AA2,54,8 (L) The prescription drug importation program under this section shall comply to the extent practical and feasible, before the prescription drug to be imported comes into the possession of the state's wholesale distributor and fully after the prescription drug to be imported is in the possession of the state's wholesale distributor, with tracking and tracing requirements of 21 USC 360eee to 360eee-1.

AB68-ASA2-AA2,54,11 (m) The prescription drug importation program under this section shall establish a fee or other mechanism to finance the program that does not jeopardize significant savings to residents of the state.

AB68-ASA2-AA2,54,13 (n) The prescription drug importation program under this section shall have an audit function that ensures all of the following:

AB68-ASA2-AA2,54,16 1. The commissioner has a sound methodology to determine the most cost-effective prescription drugs to include in the importation program under this section.

AB68-ASA2-AA2,54,18 2. The commissioner has a process in place to select Canadian suppliers that are high quality, high performing, and in full compliance with Canadian laws.

AB68-ASA2-AA2,54,20 3. Prescription drugs imported under the program are pure, unadulterated, potent, and safe.

AB68-ASA2-AA2,54,22 4. The prescription drug importation program is complying with the requirements of this subsection.

AB68-ASA2-AA2,54,25 5. The prescription drug importation program under this section is adequately financed to support administrative functions of the program while generating significant cost savings to residents of the state.

AB68-ASA2-AA2,55,2 6. The prescription drug importation program under this section does not put residents of the state at a higher risk than if the program did not exist.

AB68-ASA2-AA2,55,4 7. The prescription drug importation program under this section provides and is projected to continue to provide substantial cost savings to residents of the state.

AB68-ASA2-AA2,55,7 (2) Anticompetitive behavior. The commissioner, in consultation with the attorney general, shall identify the potential for and monitor anticompetitive behavior in industries affected by a prescription drug importation program.

AB68-ASA2-AA2,55,18 (3) Approval of program design; certification. No later than the first day of the 7th month beginning after the effective date of this subsection .... [LRB inserts date], the commissioner shall submit to the joint committee on finance a report that includes the design of the prescription drug importation program in accordance with this section. The commissioner may not submit the proposed prescription drug importation program to the federal department of health and human services unless the joint committee on finance approves the proposed prescription drug implementation program. Within 14 days of the date of approval by the joint committee on finance of the proposed prescription drug importation program, the commissioner shall submit to the federal department of health and human services a request for certification of the approved prescription drug importation program.

AB68-ASA2-AA2,56,2 (4) Implementation of certified program. After the federal department of health and human services certifies the prescription drug importation program submitted under sub. (3), the commissioner shall begin implementation of the program, and the program shall be fully operational by 180 days after the date of certification by the federal department of health and human services. The commissioner shall do all of the following to implement the prescription drug importation program to the extent the action is in accordance with other state laws and the certification by the federal department of health and human services:

AB68-ASA2-AA2,56,5 (a) Become a licensed wholesale distributor, designate another state agency to become a licensed wholesale distributor, or contract with a licensed wholesale distributor.

AB68-ASA2-AA2,56,7 (b) Contract with one or more Canadian suppliers that meet the criteria in sub. (1) (c) and (n).

AB68-ASA2-AA2,56,11 (c) Create an outreach and marketing plan to communicate with and provide information to health plans and health insurance policies, employers, pharmacies, health care providers, and residents of the state on participating in the prescription drug importation program.

AB68-ASA2-AA2,56,14 (d) Develop and implement a registration process for health plans and health insurance policies, pharmacies, and health care providers interested in participating in the prescription drug importation program.

AB68-ASA2-AA2,56,16 (e) Create a publicly accessible source for listing prices of prescription drugs imported under the program.

AB68-ASA2-AA2,56,19 (f) Create, publicize, and implement a method of communication to promptly answer questions from and address the needs of persons affected by the implementation of the program before the program is fully operational.

AB68-ASA2-AA2,56,21 (g) Establish the audit functions under sub. (1) (n) with a timeline to complete each audit function every 2 years.

AB68-ASA2-AA2,56,24 (h) Conduct any other activities determined by the commissioner to be important to successful implementation of the prescription drug importation program under this section.

AB68-ASA2-AA2,57,2 (5) Report. By January 1 and July 1 of each year, the commissioner shall submit to the joint committee on finance a report including all of the following:

AB68-ASA2-AA2,57,4 (a) A list of prescription drugs included in the importation program under this section.

AB68-ASA2-AA2,57,7 (b) The number of pharmacies, health care providers, and health plans and health insurance policies participating in the prescription drug importation program under this section.

AB68-ASA2-AA2,57,12 (c) The estimated amount of savings to residents of the state, health plans and health insurance policies, and employers resulting from the implementation of the prescription drug importation program under this section reported from the date of the previous report under this subsection and from the date the program was fully operational.

AB68-ASA2-AA2,57,14 (d) Findings of any audit functions under sub. (1) (n) completed since the date of the previous report under this subsection.

AB68-ASA2-AA2,57,16 (6) Rulemaking. The commissioner may promulgate any rules necessary to implement this section.

AB68-ASA2-AA2,411k Section 411k. 601.59 of the statutes is created to read:

AB68-ASA2-AA2,57,18 601.59 State-based exchange. (1) Definitions. In this section: